News & Events about Horizon Therapeutics Public Ltd Co.
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it will release its fourth-quarter and full-year 2022 financial results on Wednesday, March 1, 2023, prior to the open of U.S. financial markets. In light of the recently announced agreement to be acquired by Amgen Inc. and applicable...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, MLVF, TCFC SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZNP, COUP, MLVF, TCFC PR Newswire NEW YORK, Jan. 26, 2023 NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Horizon Therapeutics Public Limited Company (NasdaqGS: HZNP) to Amgen Inc. (NasdaqGS: AMGN). Under the terms of the proposed transaction...
NEW YORK, Jan. 22, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Imara Inc. (NASDAQ: IMRA)s merger with Enliven ...
Horizon Therapeutics Public Limited (NASDAQ:HZNP Get Rating) CFO Aaron Cox sold 36,148 shares of the companys stock in a transaction dated Friday, January 13th. The stock was sold at an average price of $113.17, for a total value of $4,090,869.16. Following the completion of the transaction, the ...